CareDx, Inc. Files Form 144
CareDx, Inc. filed a Form 144 with the SEC on November 5, 2026, as reported by StreetInsider.
Stocks · News reference
Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently
CMS aligns 2027 clinical lab fees with private payors to save $1 billion, yielding positive updates for CareDx and BillionToOne tests.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
BillionToOne, Inc. 12-Month Price Target Adjusted by Analysts
Analysts have slightly increased the average 12-month price target for BillionToOne, Inc. to $129.71.
BillionToOne Reports Third Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance
BillionToOne, Inc. reported its financial results for the third quarter ended September 30, 2026, and increased its full-year 2026 revenue guidance.
8-K filing — BillionToOne, Inc. (BLLN)
Filed: 2026-11-04 AccNo: 0002070849-26-000078 Size: 448 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
BillionToOne Q3 EPS $0.32 Beats $0.19 Estimate, Sales $122.981M Beat $109.365M Estimate
BillionToOne Sees FY2027 Sales $460.000M-$470.000M vs $573.800M Est